The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
A systematic review of lopinavir therapy for SARS coronavirus and MERS coronavirus—A possible reference for coronavirus disease‐19 treatment option
Open accessAbstract
In the past few decades, coronaviruses have risen as a global threat to public health. Currently, the outbreak of coronavirus disease‐19 (COVID‐19) from Wuhan caused a worldwide panic. There are no specific antiviral therapies for COVID‐19. However, there are agents that were used during the severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) epidemics. We could learn from SARS and MERS. Lopinavir (LPV) is an effective agent that inhibits the protease activity of coronavirus. In this review, we discuss the literature on the efficacy of LPV in vitro and in vivo, especially in patients with SARS and MERS, so that we might clarify the potential for the use of LPV in patients with COVID‐19.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969
Self-citationIsolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia
Zaki, A. M., van Boheemen, S., Bestebroer, T. M., Osterhaus, A. D. M. E., & Fouchier, R. A. M. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1211721 · Cited by 5,735
Peiris, J., Chu, C., Cheng, V., Chan, K., Hung, I., Poon, L., Law, K., Tang, B., Hon, T., Chan, C., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13412-5 · Cited by 2,375
Sheahan, T. P., Sims, A. C., Leist, S. R., Schäfer, A., Won, J., Brown, A. J., Montgomery, S. A., Hogg, A., Babusis, D., Clarke, M. O., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-13940-6 · Cited by 1,738
Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings
Chu, C. M. (2004) · Thorax · doi:10.1136/thorax.2003.012658 · Cited by 1,645
Drug treatment options for the 2019-new coronavirus (2019-nCoV)
Lu, H. (2020) · BioScience Trends · doi:10.5582/bst.2020.01020 · Cited by 1,133
de Wilde, A. H., Jochmans, D., Posthuma, C. C., Zevenhoven-Dobbe, J. C., van Nieuwkoop, S., Bestebroer, T. M., van den Hoogen, B. G., Neyts, J., & Snijder, E. J. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03011-14 · Cited by 736
Chan, J. F.-W., Yao, Y., Yeung, M.-L., Deng, W., Bao, L., Jia, L., Li, F., Xiao, C., Gao, H., Yu, P., et al. (2015) · Journal of Infectious Diseases · doi:10.1093/infdis/jiv392 · Cited by 608
CHAN‐YEUNG, M., & XU, R. (2003) · Respirology · doi:10.1046/j.1440-1843.2003.00518.x · Cited by 577
SARS virus infection of cats and ferrets
Martina, B. E. E., Haagmans, B. L., Kuiken, T., Fouchier, R. A. M., Rimmelzwaan, G. F., van Amerongen, G., Peiris, J. S. M., Lim, W., & Osterhaus, A. D. M. E. (2003) · Nature · doi:10.1038/425915a · Cited by 572
Wang, Z., Chen, X., Lu, Y., Chen, F., & Zhang, W. (2020) · BioScience Trends · doi:10.5582/bst.2020.01030 · Cited by 544
In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds
Chen, F., Chan, K. H., Jiang, Y., Kao, R. Y. T., Lu, H. T., Fan, K. W., Cheng, V. C. C., Tsui, W. H. W., Hung, I. F. N., & Lee, T. S. W. (2004) · Journal of Clinical Virology · doi:10.1016/j.jcv.2004.03.003 · Cited by 534
Chan, K., Lai, S. T., Chu, C., Tsui, E. L. H., Tam, C. Y., Wong, M. M.-L., Tse, M. W., Que, T. L., Peiris, M. J. S., Sung, J. J. �., et al. (2003) · PubMed · Cited by 423
Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus
Chan, J. F. W., Chan, K.-H., Kao, R. Y. T., To, K. K. W., Zheng, B.-J., Li, C. P. Y., Li, P. T. W., Dai, J., Mok, F. K. Y., Chen, H., et al. (2013) · Journal of Infection · doi:10.1016/j.jinf.2013.09.029 · Cited by 385
HIV protease inhibitor nelfinavir inhibits replication of SARS-associated coronavirus
Yamamoto, N., Yang, R., Yoshinaka, Y., Amari, S., Nakano, T., Cinatl, J., Rabenau, H., Doerr, H. W., Hunsmann, G., Otaka, A., et al. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.04.083 · Cited by 306
Kim, U. J., Won, E.-J., Kee, S.-J., Jung, S.-I., & Jang, H.-C. (2016) · Antiviral Therapy · doi:10.3851/imp3002 · Cited by 192
[Potential antiviral therapeutics for 2019 Novel Coronavirus].
Li, H., Wang, Y., Xu, J. Y., & Cao, B. (2020) · PubMed · doi:10.3760/cma.j.issn.1001-0939.2020.0002 · Cited by 180
Self-citationMolecular dynamic simulations analysis of ritronavir and lopinavir as SARS-CoV 3CLpro inhibitors
Nukoolkarn, V., Lee, V. S., Malaisree, M., Aruksakulwong, O., & Hannongbua, S. (2008) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2008.07.030 · Cited by 176
and the Saudi Critical Care Trials group, Arabi, Y. M., Asiri, A. Y., Assiri, A. M., Jokhdar, H., Alothman, A. F., Balkhy, H. H., AlJohani, S. M., Harbi, S. A. A., Kojan, S. M., et al. (2020) · Trials · doi:10.1186/s13063-019-3846-x · Cited by 142
COVID-19 infection: the China and Italy perspectives
Chen, J., Lu, H., Melino, G., Boccia, S., Piacentini, M., Ricciardi, W., Wang, Y., Shi, Y., & Zhu, T. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2603-0 · Cited by 139
Self-citationSpanakis, N., Tsiodras, S., Haagmans, B. L., Raj, V. S., Pontikis, K., Koutsoukou, A., Koulouris, N. G., Osterhaus, A. D. M. E., Koopmans, M., & Tsakris, A. (2014) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2014.07.026 · Cited by 123
Hydroxychloroquine for the Prevention of Covid-19 — Searching for Evidence
Cohen, M. S. (2020) · New England Journal of Medicine · doi:10.1056/nejme2020388 · Cited by 112
Middle East Respiratory Syndrome (MERS-CoV): World Health Organization Responses
Salaam-Blyther, T. (2015) · University of North Texas Digital Library (University of North Texas) · Cited by 108
Zhang, X. W., & Yap, Y. L. (2004) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2004.03.035 · Cited by 98
Post-exposure prophylaxis for Middle East respiratory syndrome in healthcare workers
Park, S. Y., Lee, J. S., Son, J. S., Ko, J. H., Peck, K. R., Jung, Y., Woo, H., Joo, Y., Eom, J. S., & Shi, H. (2018) · Journal of Hospital Infection · doi:10.1016/j.jhin.2018.09.005 · Cited by 78
Azim, K. F., Ahmed, S. R., Banik, A., Khan, M. M. R., Deb, A., & Somana, S. R. (2020) · Informatics in Medicine Unlocked · doi:10.1016/j.imu.2020.100367 · Cited by 76
Antiviral Treatment Guidelines for Middle East Respiratory Syndrome
Chong, Y. P., Song, J. Y., Seo, Y. B., Choi, J., Shin, H., & Rapid Response Team (2015) · Infection and Chemotherapy · doi:10.3947/ic.2015.47.3.212 · Cited by 74
Effectiveness and safety of available treatments for COVID-19 during pregnancy: a critical review
Favilli, A., Gentili, M. M., Raspa, F., Giardina, I., Parazzini, F., Vitagliano, A., Borisova, A. V., & Gerli, S. (2020) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2020.1774875 · Cited by 57
Vastag, B. (2003) · JAMA · doi:10.1001/jama.290.13.1695 · Cited by 34
Cited by
Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review
Sanders, J. M., Monogue, M. L., Jodlowski, T. Z., & Cutrell, J. B. (2020) · JAMA · doi:10.1001/jama.2020.6019 · Cited by 2,347
Clinical features of COVID-19 in elderly patients: A comparison with young and middle-aged patients
Liu, K., Chen, Y., Lin, R., & Han, K. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.03.005 · Cited by 1,642
COVID‐19 diagnosis and management: a comprehensive review
Pascarella, G., Strumia, A., Piliego, C., Bruno, F., Del Buono, R., Costa, F., Scarlata, S., & Agrò, F. E. (2020) · Journal of Internal Medicine · doi:10.1111/joim.13091 · Cited by 1,369
The epidemiology, diagnosis and treatment of COVID-19
Zhai, P., Ding, Y., Wu, X., Long, J., Zhong, Y., & Li, Y. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105955 · Cited by 1,014
COVID-19: Current understanding of its Pathophysiology, Clinical presentation and Treatment
Parasher, A. (2021) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2020-138577 · Cited by 776
Metadata
- Authors
- Yao, T., Qian, J., Zhu, W., Wang, Y., & Wang, G.
- Venue
- Journal of Medical Virology
- Publisher
- Wiley
- Published
- 2020-03-12
- Volume
- 92
- Issue
- 6
- Pages
- 556-563
- ISSN
- 0146-6615 (ISSN-L)
- 1096-9071
- OpenAlex
- W3008131087
- Cited by
- 469
- References
- 29
- FWCI
- 6.44
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.